137 related articles for article (PubMed ID: 9860239)
1. Eosinophil leukocyte degranulation in response to serum-opsonized beads: C5a and platelet-activating factor enhance ECP release, with roles for protein kinases A and C.
Egesten A; Malm J
Allergy; 1998 Nov; 53(11):1066-73. PubMed ID: 9860239
[TBL] [Abstract][Full Text] [Related]
2. Eosinophil granulocyte interaction with serum-opsonized particles: binding and degranulation are enhanced by tumor necrosis factor alpha.
Egesten A; Blom M; Calafat J; Janssen H; Knol EF
Int Arch Allergy Immunol; 1998 Feb; 115(2):121-8. PubMed ID: 9482700
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of human eosinophil activation by complement protein C5a and platelet-activating factor: similar functional responses are accompanied by different morphologic alterations.
Zeck-Kapp G; Kroegel C; Riede UN; Kapp A
Allergy; 1995 Jan; 50(1):34-47. PubMed ID: 7741187
[TBL] [Abstract][Full Text] [Related]
4. Degranulation from human eosinophils stimulated with C3a and C5a.
Takafuji S; Tadokoro K; Ito K; Dahinden CA
Int Arch Allergy Immunol; 1994; 104 Suppl 1(1):27-9. PubMed ID: 8156000
[TBL] [Abstract][Full Text] [Related]
5. Phorbol ester-induced degranulation in adherent human eosinophil granulocytes is dependent on CD11/CD18 leukocyte integrins.
Egesten A; Gullberg U; Olsson I; Richter J
J Leukoc Biol; 1993 Mar; 53(3):287-93. PubMed ID: 8095965
[TBL] [Abstract][Full Text] [Related]
6. A novel thromboxane synthetase inhibitor, DP-1904, inhibits human blood eosinophil degranulation.
Agrawal DK; Takami M; Ono S
Inflammation; 1997 Feb; 21(1):1-8. PubMed ID: 9179617
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the release of eosinophil cationic protein by eosinophil adhesion.
Xu X; Håkansson L
Clin Exp Allergy; 2000 Jun; 30(6):794-806. PubMed ID: 10848898
[TBL] [Abstract][Full Text] [Related]
8. Effects of interleukin (IL)-3 and IL-5 on human eosinophil degranulation induced by complement components C3a and C5a.
Takafuji S; Tadokoro K; Ito K
Allergy; 1996 Aug; 51(8):563-8. PubMed ID: 8874660
[TBL] [Abstract][Full Text] [Related]
9. Eosinophils maintain their capacity to signal and release eosinophil cationic protein upon repetitive stimulation with the same agonist.
Simon HU; Weber M; Becker E; Zilberman Y; Blaser K; Levi-Schaffer F
J Immunol; 2000 Oct; 165(7):4069-75. PubMed ID: 11034418
[TBL] [Abstract][Full Text] [Related]
10. Effects of PAF, FMLP and opsonized zymosan on the release of ECP, elastase and superoxide from human granulocytes.
Turner NC; Wood LJ; Foster M; Gueremy T
Eur Respir J; 1994 May; 7(5):934-40. PubMed ID: 8050551
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of protein kinases A and C demonstrates dual modes of response in human eosinophils stimulated with platelet-activating factor.
Takizawa T; Kato M; Kimura H; Suzuki M; Tachibana A; Obinata H; Izumi T; Tokuyama K; Morikawa A
J Allergy Clin Immunol; 2002 Aug; 110(2):241-8. PubMed ID: 12170264
[TBL] [Abstract][Full Text] [Related]
12. Release of granule proteins from human eosinophils stimulated with mast-cell mediators.
Takafuji S; Tadokoro K; Ito K; Nakagawa T
Allergy; 1998 Oct; 53(10):951-6. PubMed ID: 9821474
[TBL] [Abstract][Full Text] [Related]
13. The influence of IL-3, IL-5, and GM-CSF on normal human eosinophil and neutrophil C3b-induced degranulation.
Carlson M; Peterson C; Venge P
Allergy; 1993 Aug; 48(6):437-42. PubMed ID: 8238799
[TBL] [Abstract][Full Text] [Related]
14. Eosinophil degranulation in the presence of lung fibroblasts.
Takafuji S; Shoji S; Ito K; Yamamoto K; Nakagawa T
Int Arch Allergy Immunol; 1998 Sep; 117 Suppl 1():52-4. PubMed ID: 9758898
[TBL] [Abstract][Full Text] [Related]
15. Effects of human lung fibroblasts on eosinophil degranulation.
Takafuji S; Miyakuni Y; Nakagawa T; Shoji S; Murata S; Yamamoto K; Ito K
Allergy; 2000 Dec; 55(12):1170-8. PubMed ID: 11117275
[TBL] [Abstract][Full Text] [Related]
16. Effects of physiologic soluble agonists on leukotriene C4 production and degranulation by human eosinophils.
Takafuji S; Tadokoro K; Ito K; Dahinden CA
Int Arch Allergy Immunol; 1995; 108 Suppl 1():36-8. PubMed ID: 7549519
[TBL] [Abstract][Full Text] [Related]
17. Differential inhibition of inflammatory effector functions by petasin, isopetasin and neopetasin in human eosinophils.
Thomet OA; Wiesmann UN; Blaser K; Simon HU
Clin Exp Allergy; 2001 Aug; 31(8):1310-20. PubMed ID: 11529903
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of formoterol on platelet-activating factor induced eosinophil chemotaxis and degranulation.
Eda R; Sugiyama H; Hopp RJ; Okada C; Bewtra AK; Townley RG
Int Arch Allergy Immunol; 1993; 102(4):391-8. PubMed ID: 8241801
[TBL] [Abstract][Full Text] [Related]
19. Pertussis toxin shows distinct early signalling events in platelet-activating factor-, leukotriene B4-, and C5a-induced eosinophil homotypic aggregation in vitro and recruitment in vivo.
Teixeira MM; Giembycz MA; Lindsay MA; Hellewell PG
Blood; 1997 Jun; 89(12):4566-73. PubMed ID: 9192781
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of non-selective and selective phosphodiesterase inhibitors on human eosinophil functions.
Hatzelmann A; Tenor H; Schudt C
Br J Pharmacol; 1995 Feb; 114(4):821-31. PubMed ID: 7539697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
